Miller credits a 25% drop in weight with yearly savings in healthcare spending per person and brings up retatrutide's results.
Recap by typeshit. Post by Katie Miller on X.
The first four weeks cost around 129,800 won at supply price. Hanmi reports 9.75% average weight loss over 40 weeks and has set a 100 billion won first-year sales target.
Prof Jeanne Lubbe and Discovery Health weigh in. Discovery says GLP-1 claims tripled from 2022 to 2025, with members claiming for 5.4 months on average.
A guide to employer plans, Medicare Part D's weight-loss exclusion, Medicaid and paying cash, plus how added uses like sleep apnea open coverage.
Employers on the Andel marketplace set their own contribution toward Wegovy, the daily Wegovy pill and Wegovy HD, with manufacturer-direct pricing and no insurance involved.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
InSight Crime looks at how smuggling of weight loss drugs like Ozempic and Mounjaro has grown in Brazil this year and how the trade works.
Loading…